Canadian Psychiatric Association
 

Editorial Credits/ Crédits éditorials

Subscription Rates /Prix d'abonnements

Advertising Rates / Tarifs publicitaires (PDF)


Editorial
Challenges at the Pharmaceutical–Physician Boundary
Quentin Rae-Grant
(PDF)

Guest Editorial
Suicide: The Persisting Challenge
Isaac Sakinofsky
(PDF)


In Review
The Neurobiology of Suicide and Suicidality

Kees van Heeringen

(PDF)

Assessing Suicidal Youth With Antisocial, Borderline, or Narcissistic Personality Disorder
Paul S Links, Brent Gould, Ruwan Ratnayake

(PDF)


Original Research
Sexsomnia — A New Parasomnia?

Colin M Shapiro, Nikola N Trajanovic, J Paul Fedoroff

(PDF)

A Case–Control Study on Psychological Symptoms in Sleep Apnea-Hypopnea Syndrome
Weihua Yue, Wei Hao, Pozi Liu, Tieqiao Liu, Ming Ni, Qi Guo

(PDF)

Suicide Attempts in Turkey: Results of the WHO–EURO Multicentre Study on Suicidal Behaviour
Halise Devrimci-Ozguven, Is1k Say1l

(PDF)


Review Paper
Adverse Effects Associated With Physical Restraint

Wanda K Mohr, Theodore A Petti, Brian D Mohr

(PDF)


Brief Communication
Insight and Neuropsychological Function in Patients With Schizophrenia and Bipolar Disorder With Psychotic Features

Luca Arduini, Artemis Kalyvoka, Paolo Stratta, Osvaldo Rinaldi, Enrico Daneluzzo, Alessandro Rossi

(PDF)

Time of Day Influences Nonattendance at Urgent Short-Term Mental Health Unit in Victoria, British Columbia
Rivian Weinerman, Vi Glossop, Randy Wong, Lara Robinson, Karen White, Rif Kamil

(PDF)

Diabetes Mellitus and Impaired Glucose Tolerance in Patients With Schizophrenia
Mythily Subramaniam, Siow-Ann Chong, Elaine Pek

(PDF)


Book Reviews
(PDF)

Language Impairment and Psychopathology in Infants, Children and Adolescents.
Reviewed by
JH Beitchman, MD

Women’s Mental Health: A Comprehensive Textbook.
Reviewed by
Gail Erlick Robinson, MD, DPsych, FRCPC

Psychiatric and Cognitive Disorders in Parkinson’s Disease.
Reviewed by
Erwin K Koranyi, MD

Un jour la santé.
Reviewed by
Paul Beaudry, MD, FRCP

Seeking Safety: A Treatment Manual for Posttraumatic Stress Disorder and Substance Abuse.
Reviewed by
George A Fraser, MD

Treatment-Resistant Mood Disorders.
Reviewed by
Sagar V Parikh, MD, FRCPC


Letters to the Editor
(PDF)

QTc Prolongation: Chlorpromazine and High-Dosage Olanzapine

Should Lipids be Monitored During the First Year of Treatment with an Atypical Antipsychotic?

Quetiapine May Induce Mania: A Case Report

Insight, Knowledge, and Beliefs About Illness in First-Episode Psychosis

The Symptoms of Atypical Depression

Potential Risk of Diabetes Mellitus With the Use of Atypical Antipsychotic Medication

Clozapine-Induced Aplastic Anemia in a Patient With Parkinson’s Disease

Early-Onset Obsessive–Compulsive Disorder

Treatment Noncompliance With Orally Disintegrating Olanzapine Tablets

Letters to the Editor

Insight, Knowledge, and Beliefs About Illness in First-Episode Psychosis

Dear Editor:

Psychoeducation about psychosis is a valuable therapeutic strategy in that it may improve understanding of the illness itself and potentially modify patients’ behaviours and attitudes (1). In our comprehensive Early Psychosis Program (EPP), we offer education about the illness in family intervention sessions and through case and psychiatric management with a specifically designed Psychosis Education Group (2). We describe here a study that explored the impact of providing education about psychosis to individuals experiencing a first episode of a psychotic illness. Of the 78 subjects, 57 were men and 21 were women (mean age 24.7 years). They had been attending EPP as outpatients for between 12 and 30 months and had either full or partial remission of positive symptoms. We designed a multiple-choice questionnaire (the Knowledge About Psychosis Questionnaire) based on existing knowledge questionnaires in the literature and on the material taught in our program (3). We used the Insight Scale (4) to obtain information on insight regarding psychiatric illness (that is, attribution of symptoms, awareness of illness, and need for treatment). We administered the Personal Beliefs About Illness Questionnaire (PBIQ) (5) to obtain patients’ current beliefs about their illness and the degree to which patients felt that the social and scientific beliefs about their illness reflect statements about themselves. The PBIQ assesses beliefs about control over the psychotic illness; about the perception of the self as illness; and about expectations, stigma, and social containment. Both scales have good test–retest reliability and validity (4,5).

Overall, individual patients were knowledgeable about their illness: 90% answered correctly on at least 75% of the items. Good knowledge was significantly associated with good insight about the psychotic illness (P < 0.05). However, having good knowledge about the facts of the illness was not related to individuals’ beliefs about the illness. Further, those who demonstrated good insight did not necessarily demonstrate positive beliefs about the illness. Pearson correlational analyses revealed that those demonstrating good insight endorsed items on the PBIQ that suggested lack of control over the illness (P < 0.001), expectations of requiring care for the illness (P < 0.01), experiences of stigma (P < 0.05), and the need for social containment (P < 0.05).

These data imply that offering education to individuals with psychosis, even when they demonstrate good insight into the illness, may not be enough. Rather, these data support the need to understand and address the beliefs individuals hold about their psychosis—beliefs that tend to reflect negative statements about themselves. Such beliefs may lead to secondary morbidity following illness onset. Recent support for cognitive-behavioural therapy (CBT) with first-episode subjects (6) implies that CBT may be an appropriate intervention to help challenge some of the personal beliefs that may impact negatively on outcome.

References

1. Albiston D, Carbone S, Cowling V, Francey S, Haines S, McGrath P, and others. Psychoeducation in early psychosis. Victoria (Australia): Promotions Unit, Department of Human Services; 1997. p 1–13.

2. Addington J, Addington D. Early intervention for psychosis: The Calgary early psychosis treatment and prevention program. CPA Bulletin 2001;33:1–6.

3. Barraclough C, Tarrier N, Watts S, Vaughn C, Bamrah J, Freeman H. Assessing the functional value of relatives’ knowledge about schizophrenia. A preliminary report. Br J Psychiatry 1987;151:1–8.

4. Birchwood M, Smith J, Drury V, Healy J, MacMillan F, Slade M. A self-report insight scale for psychosis: reliability, validity and sensitivity to change. Acta Psychiatr Scand 1994;89:62–7.

5. Birchwood M, Mason R, MacMillan F, Healy J. Depression, demoralization and control over psychotic illness: a comparison of depressed and non-depressed patients with a chronic psychosis. Psychol Med 1993;23:387–95.

6. Sensky T, Tukington T, Kingdon D, and others. A randomized controlled trial of cognitive behavior therapy for persistent positive symptoms in schizophrenia resistant to medication. Arch Gen Psychiatry 2000;57:165–73.

Laura Quillams,
BA Calgary, Alberta
Jean Addington, PhD
Toronto, Ontario




CJP Archives in English | Archives RCP en français
Supplements and Position Paper Inserts |
Lignes directrices cliniques, énoncés de principe et communiqués
Author Index to 2002 | Index RCP des auteurs 2002
Subject Index to 2002 | Index RCP des sujets 2002
Information for Contributors | Information à l'intention des auteurs
Style Notes for Contributors
Subscription Rates | Prix d'abonnements
Advertising Rates | Tarifs publicitaires
CPA Home | Page d'accueil